Moderna
MRNA
#1653
Rank
S$16.21 B
Marketcap
S$41.49
Share price
-7.48%
Change (1 day)
-22.68%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$16.21 Billion

As of December 2025 Moderna has a market cap of S$16.21 Billion. This makes Moderna the world's 1653th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025S$16.21 B-22.77%
2024S$20.99 B-58.08%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Moderna was reported to be:

S$17.51 Billion
by Nasdaq info icon info icon
S$17.52 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
S$0.72 B-95.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$337.12 B 1,979.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$1.07 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$67.68 B 317.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$343.02 B 2,015.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
S$12.40 B-23.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$637.04 B 3,829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.82 B-76.40%๐Ÿ‡บ๐Ÿ‡ธ USA